tiprankstipranks
Kissei Pharmaceutical Co (JP:4547)
:4547

Kissei Pharmaceutical Co (4547) Price & Analysis

Compare
0 Followers

4547 Stock Chart & Stats


---

Financials

Quarterly

Options Prices

Currently, No data available
---

Ownership Overview

4.84%0.18%91.23%
Insiders
0.18% Other Institutional Investors
91.23% Public Companies and
Individual Investors

4547 FAQ

What was Kissei Pharmaceutical Co ’s price range in the past 12 months?
Kissei Pharmaceutical Co lowest stock price was ¥3000.00 and its highest was ¥4270.00 in the past 12 months.
    What is Kissei Pharmaceutical Co ’s market cap?
    Kissei Pharmaceutical Co ’s market cap is ¥154.72B.
      When is Kissei Pharmaceutical Co ’s upcoming earnings report date?
      Kissei Pharmaceutical Co ’s upcoming earnings report date is May 13, 2025 which is in 61 days.
        How were Kissei Pharmaceutical Co ’s earnings last quarter?
        Kissei Pharmaceutical Co released its earnings results on Feb 03, 2025. The company reported ¥82.65 earnings per share for the quarter, missing the consensus estimate of ¥85.023 by -¥2.373.
          Is Kissei Pharmaceutical Co overvalued?
          According to Wall Street analysts Kissei Pharmaceutical Co ’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Kissei Pharmaceutical Co pay dividends?
            Kissei Pharmaceutical Co pays a Annually dividend of ¥45 which represents an annual dividend yield of 2.42%. See more information on Kissei Pharmaceutical Co dividends here
              What is Kissei Pharmaceutical Co ’s EPS estimate?
              Kissei Pharmaceutical Co ’s EPS estimate is 83.08.
                How many shares outstanding does Kissei Pharmaceutical Co have?
                Kissei Pharmaceutical Co has 47,911,186 shares outstanding.
                  What happened to Kissei Pharmaceutical Co ’s price movement after its last earnings report?
                  Kissei Pharmaceutical Co reported an EPS of ¥82.65 in its last earnings report, missing expectations of ¥85.023. Following the earnings report the stock price went up 0.379%.
                    Which hedge fund is a major shareholder of Kissei Pharmaceutical Co ?
                    Currently, no hedge funds are holding shares in JP:4547
                    ---

                    Company Description

                    Kissei Pharmaceutical Co

                    Kissei Pharmaceutical Co., Ltd. engages in the research, development, manufacture and sale of pharmaceutical products and health foods. It operates through the following segments: Ethical Pharmaceuticals and Others. The Ethical Pharmaceuticals segment researches, develops, manufactures, and markets drugs, which are used in the fields of urology, dialysis, women's health, ophthalmology, endocrinology and metabolism. The Others segment includes sales of materials and other goods, information solution services, construction subcontracting, and facilities and equipment management. The company was founded on August 9, 1946 and is headquartered in Matsumoto, Japan.
                    ---

                    4547 Stock 12 Month Forecast

                    Average Price Target

                    ¥3,929.31
                    ▲(7.51% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3015":"¥3,015","3930":"¥3,930","3243.75":"¥3,243.8","3472.5":"¥3,472.5","3701.25":"¥3,701.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":3929.3108546985,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥3.93K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3929.3108546985,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥3.93K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3929.3108546985,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥3.93K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3015,3243.75,3472.5,3701.25,3930],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2023","6":"Mar<br/>2024","9":"Jun<br/>2024","12":"Dec<br/>2024","25":"Dec<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3700,3717.639296515269,3735.2785930305386,3752.9178895458076,3770.557186061077,3788.196482576346,3805.835779091615,3823.4750756068847,3841.114372122154,3858.753668637423,3876.3929651526923,3894.0322616679614,3911.671558183231,{"y":3929.3108546985,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3700,3717.639296515269,3735.2785930305386,3752.9178895458076,3770.557186061077,3788.196482576346,3805.835779091615,3823.4750756068847,3841.114372122154,3858.753668637423,3876.3929651526923,3894.0322616679614,3911.671558183231,{"y":3929.3108546985,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3700,3717.639296515269,3735.2785930305386,3752.9178895458076,3770.557186061077,3788.196482576346,3805.835779091615,3823.4750756068847,3841.114372122154,3858.753668637423,3876.3929651526923,3894.0322616679614,3911.671558183231,{"y":3929.3108546985,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3327.792,"date":1693526400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3284.84,"date":1696118400000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3138.413,"date":1698796800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3050.557,"date":1701388800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3016.391,"date":1704067200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3079.842,"date":1706745600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3333.649,"date":1709251200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3421.867,"date":1711929600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3550.249,"date":1714521600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3105.85,"date":1717200000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3189.792,"date":1719792000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3189.792,"date":1719792000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3700,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Astellas Pharma
                    Chugai Pharmaceutical Co
                    Eisai Co
                    Shionogi & Co
                    Takeda Pharmaceutical Co

                    Best Analysts Covering 4547

                    1 Year
                    No data currently available
                    Popular Stocks
                    ---
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis